-
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)
(PA-18-926)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Applications are accepted on a rolling basis and reviewed approximately four times a year (November, February, April, and May). Submit by the first of the preceding month to have your application reviewed at one of the listed months.
For awards before the end of a fiscal yearSeptember 30application should be submitted no later than April 1. Applications received after this date are considered for funding in the next fiscal year.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional)
(PA-18-927)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply
, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
-
Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional)
(PA-18-928)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply
, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
-
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
(PA-18-932)
Office of Disease Prevention
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is February 5, 2019.
-
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
(PAR-18-923)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 14, 2019; January 14, 2020; January 14, 2021,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
(PAR-18-924)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 1, 2018, February 14, 2019, May 14, 2019, November 1, 2019, and February 13, 2020,by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
(PAR-18-925)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 1, 2018, February 14, 2019, May 14, 2019, November 1, 2019, and February 13, 2020,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed)
(PAR-18-929)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 21, 2018 then Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)
(PAR-18-930)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is February 5, 2019.
-
Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed)
(PAR-18-931)
National Cancer Institute
Application Receipt Date(s): December 15, 2018, by 10:00 AM EDT.
Late applications will not be accepted.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
(RFA-CA-19-002)
National Cancer Institute
Application Receipt Date(s): February 22, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional)
(RFA-DA-19-013)
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional)
(RFA-DA-19-014)
National Institute on Drug Abuse
Application Receipt Date(s): December 14, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 - Clinical Trial Optional)
(RFA-DA-19-015)
National Institute on Drug Abuse
Application Receipt Date(s): December 14, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Research Sites) (UM1 - Clinical Trial Required)
(RFA-DA-19-016)
National Institute on Drug Abuse
Application Receipt Date(s): December 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Data Coordinating Center) (UM1 - Clinical Trials Not Allowed)
(RFA-DA-19-017)
National Institute on Drug Abuse
Application Receipt Date(s): December 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
(RFA-DE-19-005)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): December 5, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)
(RFA-DK-18-501)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 20, 2018 by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional)
(RFA-DK-18-502)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 20, 2018, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement.?
-
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)
(RFA-DK-18-507)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): November 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applicationsallowed for this funding opportunity are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
-
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DK-18-508)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applicationsapplications allowed for this funding opportunity are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
-
Research Centers in Minority Institutions (RCMI) (U54)- Clinical Trials Optional
(RFA-MD-18-012)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): November 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)
(RFA-MH-19-148)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): January 22, 2019 and January 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed)
(RFA-MH-19-149)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): January 22, 2019 ; January 24, 2020,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional)
(RFA-MH-19-510)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): November 19, 2018 and March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional)
(RFA-MH-19-511)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): November 19, 2018 and March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
(RFA-NS-18-042)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Library of Medicine
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): November 27, 2018; February 11, 2019; July 11,2019; November 12 , 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
(RFA-NS-18-043)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Library of Medicine
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019 , by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
(RFA-NS-18-046)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.